Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function

Class:IdLiteratureReference:9728515
_displayNameSodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function
_timestamp2021-04-21 10:11:05
author[Person:9728501] Chan, Yi-Hsin
[Person:9728523] Hsu, Tzyy-Jer
[Person:9728540] Wang, Chun-Li
[Person:9728536] Kao, Yi-Wei
[Person:9728537] Huang, Chien-Ying
[Person:9728510] Chu, Pao-Hsien
created[InstanceEdit:9728508] Jassal, Bijay, 2021-04-21
journalESC Heart Fail
pages2784-2796
pubMedIdentifier32627380
titleSodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function
volume7
year2020
(literatureReference)[Summation:9728530] The human gene SLC5A2 encodes sodium/glucose cotransporter 2...
[Change default viewing format]
No pathways have been reviewed or authored by Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function (9728515)